Showing results (81-90 of 113) with videos related to
Sort By:
Pageof 12
The Journal of Infectious Diseases|March 19, 2010
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infectionMartin Markowitz, Florin Vaida, C Bradley Hare, et al.Lancet (London, England)|April 10, 2007
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsBonaventura Clotet, Nicholas Bellos, Jean-Michel Molina, et al.Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.Science Translational Medicine|January 16, 2015
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challengeChasity D Andrews, Yun Lan Yueh, William R Spreen, et al.Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.Retrovirology|September 13, 2014
Early immune adaptation in HIV-1 revealed by population-level approachesEric Martin, Jonathan M Carlson, Anh Q Le, et al.Journal of Virology|February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infectionAndrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.The Journal of Infectious Diseases|January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infectionAmie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.Pageof 12